论文部分内容阅读
短程督导化疗是当今对付结核病最主要的措施之一,它成功地抑制了结核菌的传播。但由于耐药菌株的不断增加,严重影响了结核病的治愈率,给临床化疗带来很大困难。1996年2月～1998年3月,我们试用含左氧氟沙星的短程化疗方案治疗耐药肺结核66例,疗效确切,并与利福平等常规化疗药物治疗70例对照,现总结如下。 1 临床资料 1996年2月～1998年3月,我们共收治耐药肺结核187例,初治耐药51例,复治耐药136例,本文以复治耐药病例为
Short-range superficial chemotherapy is one of the most important measures to deal with TB today, it successfully inhibited the spread of TB. However, due to the continuous increase of resistant strains, the cure rate of tuberculosis is severely affected, which brings great difficulties to clinical chemotherapy. February 1996 ~ March 1998, we try levofloxacin-containing short-course chemotherapy in the treatment of 66 cases of drug-resistant pulmonary tuberculosis, the exact effect, and routine chemotherapy with rifampicin 70 cases of control, are summarized below. 1 Clinical data February 1996 ~ March 1998, we received a total of 187 cases of drug-resistant pulmonary tuberculosis, first-line drug resistance in 51 cases, 136 cases of retreatment-resistant, this paper retreatment of resistant cases were